Key Drivers
- Margin strength
- Cash burn
- High leverage
AIAI Summary
GH is transitioning from a pure validation story to a reimbursement-backed commercialization story, with Shield CRC's guideline support and payer coverage creating the clearest upside path, but the stock now depends on proving durable adoption fast enough to offset heavy cash burn, debt, and execution risk.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Margin strength
- •Cash burn
- •High leverage
GH shows strong gross margins and near-term liquidity, but it remains unprofitable, cash-burning, and heavily leveraged, with only modest quarter-over-quarter improvement and a valuation that still depends on future margin expansion.
Price Behavior
Key Price Behavior Insights:
- •Strong breakout
- •Higher highs
- •Stretched rally
Over the last month, GH broke out sharply from $127 to about $168, holding above the $130-$133 zone with strong higher highs, but the fast advance leaves it stretched and vulnerable to a pullback unless $150 holds.
Rapid climb from $127.03 to $167.98, peaking at $170.77, signals short-term pullback risk
Sentiment & News
Key News Insights:
- •Deal Progress
- •FDA Validation
- •Payer Coverage
Gamehost advanced its $13.65/share sale to Pure Casino with shareholder and court approval, while Guardant Health notched FDA validation for Guardant360 CDx and expanded payer coverage for Shield, signaling continued regulatory and commercial momentum. #M&A
These updates are incrementally positive for both names, with Gamehost moving closer to closing and Guardant strengthening both its clinical utility and market access
Similar Companies in Healthcare
Other companies in the same sector with AI ratings